tamoxifen,Exemestane,Triptorelin
Astrazeneca,Pfizer,Azurity Pharmaceuticals
['core i', 'soft trial']
pam50 ror score in #soft trial is prognostic in #premenopausal pts w/ hr+/her2- early #bc &amp; not predictive of ofs benefit! most n+ premenopausal wmn had high-risk scores &amp; very young ones had enrichment of aggressive disease biology #asco23 #eu4health 
Breast International Group - Facilitating and accelerating breast cancer research internationally